
Gastroesophageal Reflux Disease Therapeutics Global Market Report 2025
Description
Gastroesophageal Reflux Disease Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on gastroesophageal reflux disease therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for gastroesophageal reflux disease therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastroesophageal reflux disease therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Branded; Generic
2) By Drug Class: Antacids; Proton Pump Inhibitors; Histamine Blockers; Pro-Kinetic Agents; Other Drugs Class
3) By Distribution Channel: Hospital Pharmacy; Drug Stores; General Stores; Supermarkets
4) By Application: Crohn’s Disease; Gastroesophageal Reflux Disease (GERD); Ulcerative Colitis
Subsegments:
1) By Branded: Proton Pump Inhibitors (PPIs); H2-Receptor Antagonists; Antacids; Coating Agents
2) By Generic: Generic Proton Pump Inhibitors (PPIs); Generic H2-Receptor Antagonists; Generic Antacids; Generic Coating Agents
Companies Mentioned: Pfizer Inc.; Johnson and Johnson; Novartis AG; Sanofi S.A.; AstraZeneca plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on gastroesophageal reflux disease therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for gastroesophageal reflux disease therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastroesophageal reflux disease therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Branded; Generic
2) By Drug Class: Antacids; Proton Pump Inhibitors; Histamine Blockers; Pro-Kinetic Agents; Other Drugs Class
3) By Distribution Channel: Hospital Pharmacy; Drug Stores; General Stores; Supermarkets
4) By Application: Crohn’s Disease; Gastroesophageal Reflux Disease (GERD); Ulcerative Colitis
Subsegments:
1) By Branded: Proton Pump Inhibitors (PPIs); H2-Receptor Antagonists; Antacids; Coating Agents
2) By Generic: Generic Proton Pump Inhibitors (PPIs); Generic H2-Receptor Antagonists; Generic Antacids; Generic Coating Agents
Companies Mentioned: Pfizer Inc.; Johnson and Johnson; Novartis AG; Sanofi S.A.; AstraZeneca plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Gastroesophageal Reflux Disease Therapeutics Market Characteristics
- 3. Gastroesophageal Reflux Disease Therapeutics Market Trends And Strategies
- 4. Gastroesophageal Reflux Disease Therapeutics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
- 5. Global Gastroesophageal Reflux Disease Therapeutics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Gastroesophageal Reflux Disease Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Gastroesophageal Reflux Disease Therapeutics Market Growth Rate Analysis
- 5.4. Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Gastroesophageal Reflux Disease Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Gastroesophageal Reflux Disease Therapeutics Total Addressable Market (TAM)
- 6. Gastroesophageal Reflux Disease Therapeutics Market Segmentation
- 6.1. Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Branded
- Generic
- 6.2. Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antacids
- Proton Pump Inhibitors
- Histamine Blockers
- Pro-Kinetic Agents
- Other Drug Classes
- 6.3. Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Drug Stores
- General Stores
- Supermarkets
- 6.4. Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Crohn’s Disease
- Gastroesophageal Reflux Disease (GERD)
- Ulcerative Colitis
- 6.5. Global Gastroesophageal Reflux Disease Therapeutics Market, Sub-Segmentation Of Branded, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Proton Pump Inhibitors (PPIs)
- H2-Receptor Antagonists
- Antacids
- Coating Agents
- 6.6. Global Gastroesophageal Reflux Disease Therapeutics Market, Sub-Segmentation Of Generic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Generic Proton Pump Inhibitors (PPIs)
- Generic H2-Receptor Antagonists
- Generic Antacids
- Generic Coating Agents
- 7. Gastroesophageal Reflux Disease Therapeutics Market Regional And Country Analysis
- 7.1. Global Gastroesophageal Reflux Disease Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Gastroesophageal Reflux Disease Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market
- 8.1. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Gastroesophageal Reflux Disease Therapeutics Market
- 9.1. China Gastroesophageal Reflux Disease Therapeutics Market Overview
- 9.2. China Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Gastroesophageal Reflux Disease Therapeutics Market
- 10.1. India Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Gastroesophageal Reflux Disease Therapeutics Market
- 11.1. Japan Gastroesophageal Reflux Disease Therapeutics Market Overview
- 11.2. Japan Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Gastroesophageal Reflux Disease Therapeutics Market
- 12.1. Australia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Gastroesophageal Reflux Disease Therapeutics Market
- 13.1. Indonesia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Gastroesophageal Reflux Disease Therapeutics Market
- 14.1. South Korea Gastroesophageal Reflux Disease Therapeutics Market Overview
- 14.2. South Korea Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Gastroesophageal Reflux Disease Therapeutics Market
- 15.1. Western Europe Gastroesophageal Reflux Disease Therapeutics Market Overview
- 15.2. Western Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Gastroesophageal Reflux Disease Therapeutics Market
- 16.1. UK Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Gastroesophageal Reflux Disease Therapeutics Market
- 17.1. Germany Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Gastroesophageal Reflux Disease Therapeutics Market
- 18.1. France Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Gastroesophageal Reflux Disease Therapeutics Market
- 19.1. Italy Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Gastroesophageal Reflux Disease Therapeutics Market
- 20.1. Spain Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Gastroesophageal Reflux Disease Therapeutics Market
- 21.1. Eastern Europe Gastroesophageal Reflux Disease Therapeutics Market Overview
- 21.2. Eastern Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Gastroesophageal Reflux Disease Therapeutics Market
- 22.1. Russia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Gastroesophageal Reflux Disease Therapeutics Market
- 23.1. North America Gastroesophageal Reflux Disease Therapeutics Market Overview
- 23.2. North America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Gastroesophageal Reflux Disease Therapeutics Market
- 24.1. USA Gastroesophageal Reflux Disease Therapeutics Market Overview
- 24.2. USA Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Gastroesophageal Reflux Disease Therapeutics Market
- 25.1. Canada Gastroesophageal Reflux Disease Therapeutics Market Overview
- 25.2. Canada Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Gastroesophageal Reflux Disease Therapeutics Market
- 26.1. South America Gastroesophageal Reflux Disease Therapeutics Market Overview
- 26.2. South America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Gastroesophageal Reflux Disease Therapeutics Market
- 27.1. Brazil Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Gastroesophageal Reflux Disease Therapeutics Market
- 28.1. Middle East Gastroesophageal Reflux Disease Therapeutics Market Overview
- 28.2. Middle East Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Gastroesophageal Reflux Disease Therapeutics Market
- 29.1. Africa Gastroesophageal Reflux Disease Therapeutics Market Overview
- 29.2. Africa Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Gastroesophageal Reflux Disease Therapeutics Market Competitive Landscape And Company Profiles
- 30.1. Gastroesophageal Reflux Disease Therapeutics Market Competitive Landscape
- 30.2. Gastroesophageal Reflux Disease Therapeutics Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- 31. Gastroesophageal Reflux Disease Therapeutics Market Other Major And Innovative Companies
- 31.1. Medtronic PLC
- 31.2. GlaxoSmithKline plc
- 31.3. Eisai Co. Ltd.
- 31.4. Takeda Pharmaceutical Company Limited
- 31.5. bioMerieux SA
- 31.6. Teva Pharmaceutical Industries
- 31.7. Dr. Reddy's Laboratories Ltd.
- 31.8. Amneal Pharmaceuticals LLC
- 31.9. CHEPLAPHARM Arzneimittel GmbH
- 31.10. Daewoong Pharmaceutical Co. Ltd
- 31.11. Ironwood Pharmaceuticals Inc.
- 31.12. Sebela Pharmaceuticals Inc.
- 31.13. Camber Pharmaceuticals Inc.
- 31.14. Sun Pharmaceutical Industries Ltd.
- 31.15. EndoGastric Solutions
- 32. Global Gastroesophageal Reflux Disease Therapeutics Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Gastroesophageal Reflux Disease Therapeutics Market
- 34. Recent Developments In The Gastroesophageal Reflux Disease Therapeutics Market
- 35. Gastroesophageal Reflux Disease Therapeutics Market High Potential Countries, Segments and Strategies
- 35.1 Gastroesophageal Reflux Disease Therapeutics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Gastroesophageal Reflux Disease Therapeutics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Gastroesophageal Reflux Disease Therapeutics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.